DM1 (Mertansine), 5mg

DM1 (Mertansine), an antibody-conjugatable maytansinoid, is a selective microtubuleinhibitor that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. Mertansine can be attached to a monoclonal antibody with a linker to create an antibody-drug conjugate (ADC).Solutions are unstable and should be fresh-prepared.